Trial Profile
A Study to Evaluate the Association Between Serum Adalimumab Concentrations and Endoscopic Disease Activity in Patients With Crohn's Disease (CD)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Apr 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 12 Apr 2016 New trial record
- 04 Apr 2016 Results published in the Journal of Gastroenterology and Hepatology